CHEMOTHERAPY Dr.M.Torfehnezhad Pediatrician Definition: Chemotherapy The treatment of cancer using specific chemical agents or drugs that are destructive.

Slides:



Advertisements
Similar presentations
Cytidine analogue ALL, AML
Advertisements

Prof J.E.Brown Password: CCL.
Anticancer Agents Antibiotics Classification of Antibiotics:
Cancer 101 Monica Schlatter, RN, ND, AOCNP. Types of Cancer AIDS- related malignancies AIDS- related malignancies Bone and soft tissue sarcoma Bone and.
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Antineoplastics  W hat is Cancer ? Cancer is a disorder of cell division (leading cause of death).  C C ancers most commonly occur in: breast (♀) -
Copyright © 2015 Cengage Learning® Chapter 14 Antineoplastic Drugs.
CHEMOTHERAPY An Overview Amy Sinacola. Haematology Macmillan Clinical Nurse Specialist.
Neoplasms.
Antineoplastic Agents Pharmacology II NUR 312. Principles of Chemotherapy  The goal is to eliminate all malignant cells without excessive destruction.
Cancer Chemotherapy Topics
Understanding the cell cycle - chemotherapy and beyond
Chemotherapy of Medulloblastoma By: Minh Trinh. Objectives Briefly describe chemotherapy of medulloblastoma Discuss different regimens used for therapy.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 100 Basic Principles of Cancer Chemotherapy.
Cancer therapy - conventional Surgery Radiotherapy Chemotherapy Adjuvant therapies.
Cancer Drug Classes The classes of drugs currently used in the cancer clinic are  1. DNA Binding Agents (intercalating and alkylating.
Clinical Division of Oncology Department of Medicine I Mediacal University of Vienna, Austria Principles of chemotherapy.
Patients on Chemotherapy Dr. Feras FARARJEH. General Concepts The purpose of treating cancer with chemotherapeutic agents is to prevent cancer cells from.
ANTINEOPLASTICS I: GENERAL CONCEPTS
 Identify different options of cancer therapy.  Most cancers are treated with a combination of approaches.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Pharmacology in Nursing Antineoplastic Drugs Part 1: Cancer.
ANTI-NEOPLASTIC DRUGS
By: Dr. Abdulaziz Bin Saeedan Ph.D. Department of Pharmacology E mail: P harmacology – IV PHL-425 Chapter 2: CANCER CHEMOTHERAPY:
Cancer Treatment Ashley Panakezham Rosemin Panjwani Osman Jamal Mustafa Quraishi.
Chapter 20 Antineoplastic and Immunosuppressive Drugs Copyright © 2011 Delmar, Cengage Learning.
Chapter 39 Antineoplastic Agents Department of Pharmacology, Yunyang Medical College Lu Juan( 卢娟 )
Principles of Chemotherapy. Objectives At the completion of this session the participant will be able to: ◦ Define combination chemotherapy ◦ Recognize.
Joseph A. De Soto M.D., Ph.D., F.A.I.C.
Antineoplastic Agents and Adjunct Drugs Used in Cancer Treatment.
Microtubule inhibitors
Slide 1 Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Drugs Affecting Neoplasms.
Cytotoxic Drugs. III Dr. Yieldez Bassiouni.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 20 Antineoplastic.
DH206: Pharmacology CH 23: Antineoplastic Drugs Lisa Mayo, RDH, BSDH Copyright © 2011, 2007 Mosby, Inc., an affiliate of Elsevier. All rights reserved.
PTP 546 Module 8 Pharmacology of Cancer Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
ONCOLOGY Cytotoxic Agents. ONCOLOGY Cytotoxic agents Selective toxicity based on characteristics that distinguish malignant cells from normal cells Antineoplastic.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Cytotoxic Agents.
Antineoplastics Pharmacology III Practical Sessions Cairo University
Antineoplastics 1 February :08 AM.
Cancer Chemotherapy Dr.Azarm.  The goal of cancer treatment is eradication of cancer  If not possible shifts to palliation,amelioration and preservation.
Anticancer Drugs General Pharmacology M212 Dr. Laila M. Matalqah Ph.D. Pharmacology.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 101 Anticancer Drugs I: Cytotoxic Agents.
Cancer Heather Gates RN, BSN October 20, Core Concepts in Pharmacology, 2e By Norman Holland and Michael Patrick Adams © 2007 Pearson Education,
Therapy of cancer disease This study material is recommended specifically for practical courses from Pharmacology II for students of general medicine and.
BASIS OF CANCER CHEMOTHERAPY PHL 417 Dr. Mohamed M. Sayed-Ahmed.
Cancer Chemotherapy Prof. Rafi Korenstein Dept. of Physiology and Pharmacology Faculty of Medicine, Tel-Aviv University.
LEARNING GOALS: I CAN… …understand how cancerous (malignant) tumors evolve within the body. …describe different stages in diagnosing cancer. …explain.
Cancer: Neoplasia. Cancer Abnormal, uncontrolled cell division Damage to genes controlling cell growth Cancer cells lose normal functions Divide rapidly.
Anticancer Drugs. Introduction Cancer refers to a malignant neoplasm or new growth. Cancer cells manifest uncontrolled proliferation, loss of function.
ABIRA KHAN TUMOR MARKERS & CANCER TREATMENT. TUMOR MARKERS Biological substances synthesized and released by cancer cells or produced by the host in response.
Jeopardy Oncologic Topics Chapter 23 & 24. Emergencies Treatment/SE Patient Care Prevention Patho
Feb. 17, 2014 Phase II, Foundation BlockAntineoplastics Faculty of Medicine, Kuwait University Prof. Saghir Akhtar RM 327, Phone: 6342
DEPARTMENT OF PHARMACEUTICS 1. Cancer In most cases, causes of cancer is multifactorial (environmental, genetic) 25% of population of U.S will be diagnosed.
UNIVERSITY OF LUSAKA CANCER CHEMOTHERAPY.
CHEMOTHERAPY An Overview Amy Sinacola.
Drugs Used for Cancer Treatment
Cancer Chemotherapy.
Anti- CANCER drugs Dr. Mohammed Abd-Almoneim
Microtubule inhibitors
Antineoplastic Agents
Patients on Chemotherapy
School of Pharmacy, University of Nizwa
CHEMOTHERAPY An Overview Amy Sinacola.
Chemotherapy Day 2.
Chemotherapy Vipin Patidar
ANTIMETABOLITES Antimetabolites are structurally related to normal compounds that exist within the cell They generally interfere with the availability.
Section I Basic Pharmacology of Anticancer Drug
ANTIMICROTUBULES PHL 417.
OBJECTIVES To learn the mechanism of cytotoxicity and toxicity of the commonly used antimetabolites.
Presentation transcript:

CHEMOTHERAPY Dr.M.Torfehnezhad Pediatrician

Definition: Chemotherapy The treatment of cancer using specific chemical agents or drugs that are destructive to malignant cells and tissues. The term comes from two words that mean "chemical" and "treatment." CCytotoxic literally translated means ‘toxic to cells’.

The Cell Cycle

Mitosis

Cell Biology: Mitosis A cell in mitosis

Normal Cell Characteristics: Metabolism. Strictly controlled & predictable Maturation & Specialisation. Occurrs before dividing. Strictly controlled. Reproduction = Cell death Contact Inhibition. Mechanism for switching off division when in contact with different cells Recognition. Like cells stay together.

Cancer Cell Characteristics: Unchecked & Uncontrolled Growth Loss of contact inhibition Loss of capacity to differentiate Increased growth fraction Chromosomal Instability Capacity to metastasise Altered biochemical properties

Chemotherapy and Cancer Cells Cell Cycle specific : Most active against cells in a specific phase therefore need prolonged exposure or repeated doses. Cell Cycle Non-specific: Most effective against actively dividing cells

Chemotherapy Chemotherapy may be used conventionally to: Cure patients Prolong survival Palliative care symptom control

Chemotherapy Combination Therapy. Prevents resistance. Adjuvant Therapy. Administered after primary therapy e.g.Surgery Neo adjuvant Therapy: Given before surgery to reduce tumour size.

Chemotherapy Over 50 different chemotherapy drugs Administered as an outpatient or inpatient depending on toxicity Modes of administration include: Oral e.g. Methotrexate, Hydroxyurea IV: Canula/Indwelling Central Venous Catheter Sub cut Intracavity e.g pelvic cavity, bladder Intrathecal. Can be fatal if wrong drug administered!

Intrathecal Chemotherapy

Drugs Used in Cancer Chemotherapy Cytotoxic Agents Alkylating Agents Antimetabolites Cytotoxic antibiotics Plant derivatives Hormones Suppress nat’l hormone secr’n or antagonize hormone action Misc (mostly target oncogene products)

Rand 50.3

Alkylating Agents Contain chemical groups that bind cell nucleophiles

Alkylating Agents Cisplatin (Platinol), Mechlorethamine (Mustargen) and Cytoxan are commonly used agents in this category Carboplatin- more myelotoxic Action: substitutes an alkyl chemical structure for a hydrogen atom in the DNA This results in a cross-linking of each strand of DNA, thus preventing cell division

Alkylating Agents, con’t Effective against lymphomas, leukemias, myelomas, ovarian, testicular, breast, and pancreatic cancers Cause bone marrow suppression, alteration in mucous membranes, severe N&V, alopecia

Alkylating Agents, con’t Can also cause ototoxicity and nephrotoxicity. Be sure the patient is well hydrated before receiving these agents

Cyclophosphamide Most common Prodrug – liver metab by CYP P450 MFO’s Effects lymphocytes Also immunosuppressant Oral or IV usually SE’s: n/v, bone marrow dpression, Cytoxan can cause hemorrhagic cystitis (give MESNA to protect the bladder)

Antimetabolites These drugs have a structure similar to a necessary building block for the formation of DNA. These drugs are accepted by the cell as the necessary ingredient for cell growth, but because it is an imposter, it interferes with the production of DNA.

Antimetabolites Kill cells in S phase Three main groups Folate antagonists Pyr analogs Pur analogs

Folic Acid Analogs Folic acid essential for synth purines, and thymidylate

Methotrexate Higher affinity for enz than does FH2  Inhib’n DNA synth

Pyrimidine Analogs 5-Fluorouracil Competitive inhibitor for thymidylate synthetase active site Decr’d DNA synthesis

Gemcitabine Inhib’s ribonucleotide reductase  decr’d nucleotide synth

Cytosine arabinoside (cytarabine) Inhibits DNA polymerase Gemcitabine – araC analog Fewer SE’s

Purine Analogs 6-Mercaptopurine, 6-Thioguanine Inhibit enz’s necessary for purine synth Fludarabine Converted to triphosphate Mech action sim to ara-C Pentostatin Inhibits adenosine deaminase Catalyzes adenosine  inosine Interferes w/ purinemetab, cell prolif’n

Antibiotic Antineoplastic Agents These agents actually bind DNA, thus inhibiting DNA and RNA synthesis and therefore inhibiting cell growth. Sadly, these drugs have great potential to cause irreversible cardiomyopathies. Doxorubicin (Adriamycin) is used for acute leukemias, soft tissue/bone cancers, lymphomas, and breast cancer

Antibiotic Agents, con’t Adriamycin is also a potent vessicant (will cause tissue necrosis if it infiltrates) Most dangerous side effect is decreased ejection fraction (normal is 70%). Must do baseline CV assessment prior to beginning Adriamycin (EKG, echo, angiography). Must reduce the dose of chemo at the first sign of heart failure

Antibiotic agents, con’t Other side effects include stomatitis, alopecia, bone marrow suppression, hepatic impairment.

Antibiotic agents, con’t Dactinomycin Interferes w/ RNA polymerase movement  decr’d transcr’n Bleomycin Glycopeptide Chelates Fe, which interacts w/ O2  Gen’n superoxide and/or hydroxyl radicals Radicals degrade DNA  fragmentation, release of free bases Most effective in G2, also active against cells in G0 Little myelosuppression BUT pulmonary fibrosis

Mitotic Inhibitors These drugs are also called Vinca- Alkaloids Work by inhibiting mitosis during cell division Vinblastine (Velban) and Vincristine (Oncovin) are commonly used agents for ALL, lymphomas, rhabdomyosarcoma)

Mitotic Inhibitors, con’t Neurotoxicity is a specific side effect for this classification of drugs. Peripheral neuropathy, alteration in bowel and bladder tone (including paralytic ileus), headache, tingling of fingers/hands/toes, ataxia. Constipation is common due to effects on the autonomic nervous system

Vinca Alkaloids

Etoposide, teniposide From mandrake root Inhibit mitoch function, nucleoside transport, topoisomerase II Campothecins: irinotecan, topotecan Irinotecan requires hydrolysis  active form Bind, inhibit topoisomerase II

Hormonal Agents Used to treat neoplasms that are sensitive to hormonal growth controls of the body. They interfere with growth-stimulating receptors on target tissues. Corticosteroids are considered hormonal agents. They retard lymphocytic proliferation, so they help with lymphocytic leukemias and lymphomas.

Hormonal Agents, con’t Corticosteroids also decrease edema associated with tumor growth, especially in or around the brain, spinal cord, and mediastinum. Will decrease cerebral edema. Androgens (testosterone) may be used to treat advanced breast cancer

Hormonal Agents, con’t Anti-Estrogen drugs (Tamoxifen) block the uptake of estrogen and therefore are good for tumors that contain high concentrations of estrogen receptors Estrogen may be used to treat androgen- sensitive cancers, such as prostate cancer Progestins (Depo-Provera and Megace) are used to treat endometrial cancer

Chemotherapy Side Effects Chemotherapy targets cells which are dividing rapidly. Chemotherapy cannot distinguish between normal cells and cancer cells Healthy Cells which have a high rate of growth and multiplication include cells of the bone marrow, hair, GI mucosa and skin.

Side effects greatest in other rapidly- dividing cells Bone marrow toxicity Impaired wound healing Hair follicle damage Gi epith damage Growth in children Gametes Fetus May themselves be carcinogenic

Chemotherapy Side effects contd… Side effects may be drug specific e.g. anthracyclines and cardiotoxicity, vinca alkaloids and neuropathy/constipation, bleomycin and pulmonary fibrosis Severity of side effects varies between drugs. Side effects often occur 7-14 days post treatment.

Side Effects: Acute Tumour Lysis Syndrome. A Metabolic Emergency. Occurrs due to rapid cell lysis (death) & large amounts of cell metabolites in blood. If untreated can lead to acute renal failure, cardiac arrest and death.

Side Effects: Acute Neutropenic Sepsis: Occurs due to Bone Marrow Failure and poor immune response to infection. Predisposing factors include: Neutropenia Underlying disease Chemotherapy Venous access devices

Neutropenic Sepsis Severe overwhelming infection where inadequate blood flow to the tissues results in cellular dysfunction and, if not reversed, eventual organ failure. Most common micro organism is gram negative Mortality rate 40-90%

Side Effects: Acute Haemorrhage Invading tumours e.g gastric MALT lymphomas Haemorrhagic Cystitis related to high dose Cyclophosphomide Anaphylactic Reaction

Side Effects:Bone Marrow Neutropenia: Increased risk of infection. Anaemia: Tiredness, lethargy & breathlessness Thrombocytopenia: Increased risk of bleeding

Side Effects: Gastro-Intestinal Nausea & Vomiting Diarrhoea & constipation Loss of appetite Taste Changes Mucositis

Side Effects Example of Grade 4 Mucositis

Side Effects: Body Image Hair Loss Weight Loss/ Weight Gain Long term central venous catheters Skin changes (colour, rashes, sensitivity to sunshine, dry)

Side Effects: Other Fatigue: Often multi-factorial Peripheral neuropathy Altered Kidney Function Changes in hearing (high dose Cisplatin) Cardiac Toxicity (Doxorubicin/ Idarubicin) Late Effects: Infertility, secondary malignancy, growth retardation.

Key Points: Chemotherapy is a major treatment in curing or prolonging survival in cancer patients It has a wide range of side effects depending on the drugs given. Nurses have a key role to play in caring for a patient receiving chemotherapy Safety issues are paramount in administration.

Summary: The potential benefit to the patient of treatment as an option must always outweigh the toxic effects.

Thank You

NCCN2012 Recommendations by Risk Category High (>90% emetic risk) Including AC containing regimens Three-drug combination of a HT 3 serotonin receptor antagonist, (palonosetron preferred-NCCN) dexamethasone, and aprepitant Moderate (>30% to 90% emetic risk) Two-drug combination of a HT 3 serotonin receptor antagonist and dexamethasone (+/-aprepitant for selected patients) Low (10% to 30% emetic risk) Dexamethasone 8-12 mg Minimal (<10% emetic risk No antiemetic routinely Thank You شاد باشید